清热通瘀方对COPD急性加重期的疗效观察  

Observation on treating AECOPD with the Qingre Tongyu prescription

作　　者：柯学[1] 彭俊杰[2] 欧形 

机构地区：[1]深圳市第三人民医院,广东深圳518000 [2]深圳市宝安区中医院,广东深圳518000 [3]深圳市龙岗区第五人民医院,广东深圳518000

出　　处：《中医临床研究》2018年第20期34-35,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:观察应用清热通瘀方治疗慢性阻塞性肺疾病(COPD)急性加重期的临床疗效,从而探讨中西医结合治疗该病的方法。方法:将符合纳入标准、中医证型为痰热瘀阻的82例COPD患者随机分为实验组、对照组,各41例,两组均采取常规吸氧、解痉平喘、化痰、抗炎等治疗;实验组同时给予口服清热通瘀方,对比分析两组患者治疗效果。结果:实验组患者临床治疗总有效率、CRP、肺功能指标改善程度明显高于对照组(P<0.05)。结论:采用清热通瘀方治疗COPD急性加重期的患者可以缓解患者的临床症状,并提高临床疗效。Objective:To observe the clinical effect of the Qingre Tongyu prescription(清热通瘀方)on acute exacerbation of COPD,and explore the method of the integrative medicine on treating the disease.Methods:82 patients were randomly divided into the experimental group and the control group,41 patients in each.Both groups received conventional oxygen absorption,Jiejing Pingchuan(解痉平喘),Huatan(化痰)and anti-inflammation,etc.The experimental group was given the Qingre Tongyu prescription more.Results:The total efficiency,improvement of CRP and lung function index in the experimental group were significantly higher than those in the control group(P<0.05).Conclusion:The Qingre Tongyu prescription on acute exacerbation of COPD can relieve clinical symptoms and improve clinical efficacy.

关 键 词：慢性阻塞性肺疾病 清热通瘀 痰热瘀阻 

分 类 号：R563[医药卫生—呼吸系统]